BioNTech will invest up to £1bn in UK life sciences over 10 years, launching new AI and R&D centres in London and Cambridge.

North Carolina’s success in regenerative medicine is due in part to its well-regarded life sciences industry, but equally also due to its strength in manufacturing. The state’s history in ...

It turns out SSRIs don’t just make our brains happier; they also make our T cells happier - even while they’re fighting ...

Aura Wellness today announced groundbreaking research demonstrating the effectiveness of its Pulsed Electromagnetic Field (PEMF) technology in treating benign prostatic hypertrophy (BPH). The study, ...

A new study has found the virus responsible for the common cold sore may have a role in the development of Alzheimer’s ...

The virus that causes cold sores is very common, but scientists say recent research should not be a cause for panic.

German biopharma company BioNTech has said it will commit up to £1 billion ($1.34 billion) in investment in the UK over the ...

Cambridge is set to become home to a major new research and development hub as part of a £1bn UK investment by biopharmaceutical firm BioNTech, expected to create more than 400 ...

This week a group of researchers, bioethicists, publishers and theologians are discussing the merits of human heritable genome editing.

As well as the economic and employment benefits, BioNTech’s UK investment is expected to deliver tangible improvements in healthcare. The company’s work in personalised cancer immunotherapies, already ...

Roughly five months after AstraZeneca scrapped a major investment plan in its home country, the United Kingdom has found a ...

Long before global beauty brands caught on, ancient traditions were tapping into the healing powers of local botanicals.